Condition
Severe Burns
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (2)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06968559Phase 3RecruitingPrimary
Effect of Early Dexamethasone on Major Complications and All-cause Mortality in Severe Burns
NCT07195565CompletedPrimary
Association of Continuous Renal Replacement Therapy With Mortality and Length of Stay in Critically Burned Patients
NCT03118362Phase 3CompletedPrimary
Fluid Resuscitation in Burn Patients
NCT00236093Phase 2Completed
Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
Showing all 4 trials